Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.

Olivier CB, Fan J, Askari M, Mahaffey KW, Heidenreich PA, Perino AC, Leef GC, Ho PM, Harrington RA, Turakhia MP.

Circ Cardiovasc Interv. 2019 Aug;12(8):e007604. doi: 10.1161/CIRCINTERVENTIONS.118.007604. Epub 2019 Aug 16.

PMID:
31416357
2.

Leveraging Value-Based Payment Models to Reduce Sex Differences in Care.

Khazanie P, Ho PM.

Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e006038. doi: 10.1161/CIRCOUTCOMES.119.006038. Epub 2019 Aug 16. No abstract available.

PMID:
31416348
3.

ICD-10 Coding of Type 2 Myocardial Infarction and Myocardial Injury as It Relates to US Centers for Medicare & Medicaid Services Value-Based Payment Programs.

Levy AE, Ream KS, Ho PM.

JAMA Cardiol. 2019 Aug 14. doi: 10.1001/jamacardio.2019.2818. [Epub ahead of print] No abstract available.

PMID:
31411635
4.

Nonregulated Interventions, Clinical Trial Registration, and Editorial Responsibility.

Spector-Bagdady K, Ho PM, Nallamothu BK.

Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005721. doi: 10.1161/CIRCOUTCOMES.119.005721. Epub 2019 Jun 11. No abstract available.

PMID:
31181958
5.

Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program.

Asundi A, Stanislawski M, Mehta P, Baron AE, Mull HJ, Ho PM, Zimetbaum PJ, Gupta K, Branch-Elliman W.

Infect Control Hosp Epidemiol. 2019 Aug;40(8):855-862. doi: 10.1017/ice.2019.127. Epub 2019 Jun 4.

PMID:
31159895
6.

Association Between Medication Adherence and 1-Year Major Cardiovascular Adverse Events After Acute Myocardial Infarction in China.

Shang P, Liu GG, Zheng X, Ho PM, Hu S, Li J, Jiang Z, Li X, Bai X, Gao Y, Xing C, Wang Y, Normand SL, Krumholz HM.

J Am Heart Assoc. 2019 May 7;8(9):e011793. doi: 10.1161/JAHA.118.011793.

7.

Two-part models for cost with zeros to decompose effects of covariates on probability of cost, mean nonzero cost, and mean total cost.

Liu W, Grunwald GK, Ho PM.

Stat Med. 2019 Jul 10;38(15):2767-2782. doi: 10.1002/sim.8140. Epub 2019 Mar 20.

PMID:
30895636
8.

Diagnostic Accuracy of Point-of-Care Lung Ultrasonography and Chest Radiography in Adults With Symptoms Suggestive of Acute Decompensated Heart Failure: A Systematic Review and Meta-analysis.

Maw AM, Hassanin A, Ho PM, McInnes MDF, Moss A, Juarez-Colunga E, Soni NJ, Miglioranza MH, Platz E, DeSanto K, Sertich AP, Salame G, Daugherty SL.

JAMA Netw Open. 2019 Mar 1;2(3):e190703. doi: 10.1001/jamanetworkopen.2019.0703.

9.

Is Prevalence of Atherosclerotic Risk Factors Increasing Among Young Adults? It Depends on How You Ask.

Leppert MH, Poisson SN, Sillau SH, Campbell JD, Ho PM, Burke JF.

J Am Heart Assoc. 2019 Mar 19;8(6):e010883. doi: 10.1161/JAHA.118.010883.

10.

Appropriateness of Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation: Insights From the Veterans Health Administration.

Leef GC, Perino AC, Askari M, Fan J, Ho PM, Olivier CB, Longo L, Mahaffey KW, Turakhia MP.

J Pharm Pract. 2019 Feb 21:897190019828270. doi: 10.1177/0897190019828270. [Epub ahead of print]

PMID:
30791808
11.

Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction.

Adamek KE, Ramadurai D, Gunzburger E, Plomondon ME, Ho PM, Raghavan S.

J Am Heart Assoc. 2019 Feb 5;8(3):e011448. doi: 10.1161/JAHA.118.011448.

12.

Impact of Macrolide Antibiotics on Hospital Readmissions and Other Clinically Important Outcomes in Critically Ill Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Propensity Score-Matched Cohort Study.

Kiser TH, Reynolds PM, Moss M, Burnham EL, Ho PM, Vandivier RW; Colorado Pulmonary Outcomes Research Group (CPOR).

Pharmacotherapy. 2019 Mar;39(3):242-252. doi: 10.1002/phar.2221.

PMID:
30663791
13.

Recommendations for the Use of Audit and Feedback to De-Implement Low-Value Care.

Whittington MD, Ho PM, Helfrich CD.

Am J Med Qual. 2019 Jul/Aug;34(4):409-411. doi: 10.1177/1062860618824153. Epub 2019 Jan 17. No abstract available.

PMID:
30654620
14.

Excluding the Elephant in the Room: Cardiac Arrest.

Valle JA, Ho PM.

J Am Heart Assoc. 2019 Jan 8;8(1):e011381. doi: 10.1161/JAHA.118.011381. No abstract available.

15.

Improving anti-platelet therapy adherence in the Veterans Health Administration: A randomized multi-site hybrid effectiveness-implementation study protocol.

McCreight MS, Lambert-Kerzner A, O'Donnell CI, Grunwald GK, Hebert P, Gillette M, Jneid H, Parashar A, Grossman PM, Helfrich C, Mavromatis K, Saket G, Ho PM.

Contemp Clin Trials. 2019 Feb;77:104-110. doi: 10.1016/j.cct.2018.12.005. Epub 2018 Dec 19.

PMID:
30576842
16.

Interventions to Improve Medication Adherence: A Review.

Kini V, Ho PM.

JAMA. 2018 Dec 18;320(23):2461-2473. doi: 10.1001/jama.2018.19271.

PMID:
30561486
17.

The authors reply.

Kiser TH, Burnham EL, Clark B, Ho PM, Allen RR, Moss M, Vandivier RW.

Crit Care Med. 2018 Dec;46(12):e1224-e1225. doi: 10.1097/CCM.0000000000003453. No abstract available.

PMID:
30444823
18.

Clinical Model to Predict 90-Day Risk of Readmission After Acute Myocardial Infarction.

Kini V, Peterson PN, Spertus JA, Kennedy KF, Arnold SV, Wasfy JH, Curtis JP, Bradley SM, Amin AP, Ho PM, Masoudi FA.

Circ Cardiovasc Qual Outcomes. 2018 Oct;11(10):e004788. doi: 10.1161/CIRCOUTCOMES.118.004788.

PMID:
30354578
19.

Impact of Patient Distance From Percutaneous Coronary Intervention Centers on Longitudinal Outcomes.

Valle JA, Glorioso TJ, Maddox TM, Armstrong EJ, Waldo SW, Bradley SM, Ho PM.

Circ Cardiovasc Qual Outcomes. 2018 Sep;11(9):e004623. doi: 10.1161/CIRCOUTCOMES.118.004623.

PMID:
30354548
20.

Predicting Length of Stay and the Need for Postacute Care After Acute Myocardial Infarction to Improve Healthcare Efficiency.

Wasfy JH, Kennedy KF, Masoudi FA, Ferris TG, Arnold SV, Kini V, Peterson P, Curtis JP, Amin AP, Bradley SM, French WJ, Messenger J, Ho PM, Spertus JA.

Circ Cardiovasc Qual Outcomes. 2018 Sep;11(9):e004635. doi: 10.1161/CIRCOUTCOMES.118.004635.

PMID:
30354547
21.

Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.

Van Matre ET, Reynolds PM, MacLaren R, Mueller SW, Wright GC, Moss M, Burnham EL, Ho PM, Vandivier RW, Kiser TH.

J Thromb Haemost. 2018 Dec;16(12):2492-2500. doi: 10.1111/jth.14317. Epub 2018 Nov 15.

PMID:
30347498
22.

Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program.

Asundi A, Stanislawski M, Mehta P, Barón AE, Gold H, Mull H, Ho PM, Gupta K, Branch-Elliman W.

Infect Control Hosp Epidemiol. 2018 Sep;39(9):1030-1036. doi: 10.1017/ice.2018.170.

PMID:
30226128
23.

Increased Nonopioid Chronic Pain Treatment in the Veterans Health Administration, 2010-2016.

Frank JW, Carey E, Nolan C, Kerns RD, Sandbrink F, Gallagher R, Ho PM.

Pain Med. 2019 May 1;20(5):869-877. doi: 10.1093/pm/pny149. No abstract available.

PMID:
30137520
24.

Temporal trends in the management and clinical outcomes of lower extremity arterial thromboembolism within a national Veteran population.

Prouse AF, Langner P, Plomondon ME, Ho PM, Valle JA, Barón AE, Armstrong EJ, Waldo SW.

Vasc Med. 2019 Feb;24(1):41-49. doi: 10.1177/1358863X18793210. Epub 2018 Aug 14.

PMID:
30105938
26.

Half-Dose Versus Full-Dose Alteplase for Treatment of Pulmonary Embolism.

Kiser TH, Burnham EL, Clark B, Ho PM, Allen RR, Moss M, Vandivier RW.

Crit Care Med. 2018 Oct;46(10):1617-1625. doi: 10.1097/CCM.0000000000003288.

PMID:
29979222
27.

African Americans Are Less Likely to Receive Care by a Cardiologist During an Intensive Care Unit Admission for Heart Failure.

Breathett K, Liu WG, Allen LA, Daugherty SL, Blair IV, Jones J, Grunwald GK, Moss M, Kiser TH, Burnham E, Vandivier RW, Clark BJ, Lewis EF, Mazimba S, Battaglia C, Ho PM, Peterson PN.

JACC Heart Fail. 2018 May;6(5):413-420. doi: 10.1016/j.jchf.2018.02.015. Erratum in: JACC Heart Fail. 2018 Jul;6(7):617.

28.

Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention.

Leppert MH, Poisson SN, Carroll JD, Thaler DE, Kim CH, Orjuela KD, Ho PM, Burke JF, Campbell JD.

Stroke. 2018 Jun;49(6):1443-1450. doi: 10.1161/STROKEAHA.117.020322. Epub 2018 May 2.

29.

National Trends of Hospital Performance in Acute Myocardial Infarction Care: Department of Veterans Affairs, 2011-2014.

Hess PL, Gunzburger EC, Kini V, Liu CF, Jones J, Matlock D, Heidenreich PA, Levy CR, Maddox TM, Grunwald GK, Ho PM.

Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004282. doi: 10.1161/CIRCOUTCOMES.117.004282. No abstract available.

PMID:
29650717
30.

Updates to Adherence to Hypertension Medications.

Roldan PC, Ho GY, Ho PM.

Curr Hypertens Rep. 2018 Apr 10;20(4):34. doi: 10.1007/s11906-018-0830-x. Review.

PMID:
29637312
31.

Association Between Facility-Level Utilization of Non-pharmacologic Chronic Pain Treatment and Subsequent Initiation of Long-Term Opioid Therapy.

Carey EP, Nolan C, Kerns RD, Ho PM, Frank JW.

J Gen Intern Med. 2018 May;33(Suppl 1):38-45. doi: 10.1007/s11606-018-4324-y.

32.

2018 ACC/AHA Clinical Performance and Quality Measures for Cardiac Rehabilitation: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Thomas RJ, Balady G, Banka G, Beckie TM, Chiu J, Gokak S, Ho PM, Keteyian SJ, King M, Lui K, Pack Q, Sanderson BK, Wang TY.

J Am Coll Cardiol. 2018 Apr 24;71(16):1814-1837. doi: 10.1016/j.jacc.2018.01.004. Epub 2018 Mar 29. No abstract available.

33.

2018 ACC/AHA Clinical Performance and Quality Measures for Cardiac Rehabilitation: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Thomas RJ, Balady G, Banka G, Beckie TM, Chiu J, Gokak S, Ho PM, Keteyian SJ, King M, Lui K, Pack Q, Sanderson BK, Wang TY.

Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e000037. doi: 10.1161/HCQ.0000000000000037. Review. No abstract available.

PMID:
29599285
34.

The authors reply.

Kelmenson DA, Held N, Allen RR, Quan D, Burnham EL, Clark BJ, Ho PM, Kiser TH, Vandivier RW, Moss M.

Crit Care Med. 2018 Apr;46(4):e347-e348. doi: 10.1097/CCM.0000000000002984. No abstract available.

PMID:
29538131
35.

Clinical Outcomes After Cardiac Stress Testing Among US Patients Younger Than 65 Years.

Kini V, Dayoub EJ, Hess PL, Marzec LN, Masoudi FA, Ho PM, Groeneveld PW.

J Am Heart Assoc. 2018 Mar 10;7(6). pii: e007854. doi: 10.1161/JAHA.117.007854.

36.

Frontiers in Cardiovascular Outcomes Research.

Nallamothu BK, Ho PM.

Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e004612. doi: 10.1161/CIRCOUTCOMES.118.004612. No abstract available.

PMID:
29449444
37.

An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.

Sottile PD, Kiser TH, Burnham EL, Ho PM, Allen RR, Vandivier RW, Moss M; Colorado Pulmonary Outcomes Research Group (CPOR).

Am J Respir Crit Care Med. 2018 Apr 1;197(7):897-904. doi: 10.1164/rccm.201706-1132OC.

38.

Peer Review of a Manuscript Submission: A How-To Guide for Effective and Efficient Commentary.

Allen LA, Ho PM.

Circ Cardiovasc Qual Outcomes. 2017 Dec;10(12). pii: e004446. doi: 10.1161/CIRCOUTCOMES.117.004446. No abstract available.

PMID:
29237748
39.

Peer Review of a Manuscript Submission: A How-To Guide for Effective and Efficient Commentary.

Allen LA, Ho PM.

Circ Heart Fail. 2017 Dec;10(12). pii: e004766. doi: 10.1161/CIRCHEARTFAILURE.117.004766. No abstract available.

PMID:
29237709
40.

Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project.

Hess PL, Kennedy K, Cowherd M, Virani SS, Masoudi FA, Navar AM, Yeh RW, Ho PM, Maddox TM.

Am Heart J. 2018 Jan;195:151-152. doi: 10.1016/j.ahj.2017.09.004. Epub 2017 Sep 9. No abstract available.

41.

Implementation and dissemination of a transition of care program for rural veterans: a controlled before and after study.

Leonard C, Lawrence E, McCreight M, Lippmann B, Kelley L, Mayberry A, Ladebue A, Gilmartin H, Côté MJ, Jones J, Rabin BA, Ho PM, Burke R.

Implement Sci. 2017 Oct 23;12(1):123. doi: 10.1186/s13012-017-0653-1.

42.

The Impact of De-escalation of Antianginal Medications on Health Status After Percutaneous Coronary Intervention.

Qintar M, Towheed A, Tang F, Salisbury AC, Ho PM, Grantham JA, Spertus JA, Arnold SV.

J Am Heart Assoc. 2017 Oct 20;6(10). pii: e006405. doi: 10.1161/JAHA.117.006405.

43.

Nonadherence in the Learning Healthcare System: Avoiding a Mountain by Seeing the Bumps.

Levy AE, Ho PM.

Circ Cardiovasc Qual Outcomes. 2017 Oct;10(10). pii: e004283. doi: 10.1161/CIRCOUTCOMES.117.004283. No abstract available.

44.

Outcomes of ICU Patients With a Discharge Diagnosis of Critical Illness Polyneuromyopathy: A Propensity-Matched Analysis.

Kelmenson DA, Held N, Allen RR, Quan D, Burnham EL, Clark BJ, Ho PM, Kiser TH, Vandivier RW, Moss M.

Crit Care Med. 2017 Dec;45(12):2055-2060. doi: 10.1097/CCM.0000000000002763.

45.

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Jneid H, Addison D, Bhatt DL, Fonarow GC, Gokak S, Grady KL, Green LA, Heidenreich PA, Ho PM, Jurgens CY, King ML, Kumbhani DJ, Pancholy S.

J Am Coll Cardiol. 2017 Oct 17;70(16):2048-2090. doi: 10.1016/j.jacc.2017.06.032. Epub 2017 Sep 21. No abstract available.

46.

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Jneid H, Addison D, Bhatt DL, Fonarow GC, Gokak S, Grady KL, Green LA, Heidenreich PA, Ho PM, Jurgens CY, King ML, Kumbhani DJ, Pancholy S.

Circ Cardiovasc Qual Outcomes. 2017 Oct;10(10). pii: e000032. doi: 10.1161/HCQ.0000000000000032. Review. No abstract available.

PMID:
28935817
47.

Variation in Management of Patients With Obstructive Coronary Artery Disease: Insights From the Veterans Affairs Clinical Assessment and Reporting Tool (VA CART) Program.

Sandhu A, Stanislawski MA, Grunwald GK, Guinn K, Valle J, Matlock D, Ho PM, Maddox TM, Bradley SM.

J Am Heart Assoc. 2017 Sep 12;6(9). pii: e006336. doi: 10.1161/JAHA.117.006336.

48.

Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration.

Borne RT, O'Donnell C, Turakhia MP, Varosy PD, Jackevicius CA, Marzec LN, Masoudi FA, Hess PL, Maddox TM, Ho PM.

BMC Cardiovasc Disord. 2017 Sep 2;17(1):236. doi: 10.1186/s12872-017-0671-6.

49.

Within-Hospital Variation in 30-Day Adverse Events: Implications for Measuring Quality.

Burke RE, Glorioso T, Barón AK, Kaboli PJ, Ho PM.

J Healthc Qual. 2018 May/Jun;40(3):147-154. doi: 10.1097/JHQ.0000000000000086.

PMID:
28837451
50.

Improving Transitions of Care for Veterans Transferred to Tertiary VA Medical Centers.

Burke RE, Kelley L, Gunzburger E, Grunwald G, Gokhale M, Plomondon ME, Ho PM.

Am J Med Qual. 2018 Mar/Apr;33(2):147-153. doi: 10.1177/1062860617715508. Epub 2017 Jul 9.

PMID:
28691503

Supplemental Content

Support Center